THE LILLY RESEARCH LABORATORIES
ELI LILLY AND COMPANY
Indianapolis, Ind., U.S.A.

DIRECTOR
G. H. A. CLOWES

September 19, 1923.

Dr. F.G. Banting,
160 Bloor St., W.,
Toronto, Canada.

My dear Banting:-
I must apologize for not having answered your last letter sooner. Your report regarding the situation in various European countries coincides with the information which we have obtained from a variety of sources. Mr. Showalter, our foreign representative, has Just paid a visit to
Europe and finds that in the majority of European countries they are extremely backward in the production of Insulin and that there is nothing in Europe at all comparable with our preparation either as regards quality or quantity. I certainly hope that we shall be able to get through the Committee with as little delay as possible, the agreement regarding foreign patents on which we have been working for
some time as it is very desirable that we should begin to supply Insulin, Lilly to prominent clinicians in various European countries.
You have doubtless heard of the temporary difficulty I have had with the Committee regarding the question of the discrepancy between the
Toronto and Indianapolis units. I have no doubt that this will soon be cleared up as we are all hard at work on the problem and I can not imagine that after my long cooperation with the Committee and the solution of much more difficult problems than this that we shall
experience any very considerable difficulty in getting this matter cleared up, but for the time being it has caused me considerable anxiety as a commercial corporation like Eli Lilly and Company prides itself particularly on the maintenance of its standards and we certainly have spared no expense or effort to keep our preparation on the highest possible plane of purity and unitage.